|Articles|November 1, 2012
- BioPharm International-11-01-2012
- Volume 25
- Issue 11
BioPharm International, November 2012 Issue (PDF)
Biosimilars : New Guidelines Set for Monoclonal Antibodies
Advertisement
Articles in this issue
over 13 years ago
The Transformation to Process-Centered Organizationover 13 years ago
Considerations for Scale-Up of Stem-Cell Culturesover 13 years ago
Creating a Holistic Procurement Systemover 13 years ago
Product Characterization: A Primerover 13 years ago
A 25-Year Retrospective on Protein Recovery through Membrane Filtersover 13 years ago
Assay Development and Method Validation Essentialsover 13 years ago
Discovery Pipeline: Improved Delivery of RNA Vaccinesover 13 years ago
How to Manage Effective Leadership when Change is the Only Constantover 13 years ago
Product Analysis Key to Biosimilar DevelopmentNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5
